Tradestie Institutional Equity Comparison Engine

NRIX vs CRMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NRIX Overall Edge

NRIX Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nurix Therapeutics, Inc. Common stock (NRIX) driven by superior Growth & Margin, Momentum & Technical while CRMD counters with relative strength in Valuation, Options & Structure. Fundamentally, NRIX trades at N/M Forward P/E with 41.3% operating margin (+8426.3% YoY revenue) versus CRMD at 49.0x Forward P/E and 41.0% operating margin (-47.7% YoY). In options structure, NRIX sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro) against CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRMD
NRIX N/M vs CRMD 49.0x Fwd P/E
Growth & Margin Winner NRIX
Op Margin 41.3% vs 41.0% ยท YoY +8426.3% vs -47.7%
Momentum & Technical Winner NRIX
1Y +20.8% vs -56.2% ยท 52W Pos 18% vs 3%
Options & Structure Winner CRMD
BREAKDOWN (4th %ile IV) vs BREAKDOWN (25th %ile IV)
NRIX NASDAQ
Nurix Therapeutics, Inc. Common stock
Pharmaceutical Preparations
$15.01
-3.04% 1D
Market Cap $1.7B
1M Return -38.53%
1Y Return +20.76%
Forward P/E N/M
Unified AI Score
51.5 / 100 HOLD
Tech 55.0 Fund 58.0 Flow 64.0 Mom 55.0
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.92
+5.47% 1D
Market Cap $384.7M
1M Return -32.3%
1Y Return -56.16%
Forward P/E 49.0x
Unified AI Score
53.2 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 69.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NRIX +20.76% CRMD -56.16% Spread: +76.92 pp (NRIX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NRIX Revenue CRMD Revenue NRIX Op. Margin CRMD Op. Margin Margin Edge
FY2018 N/A $0M N/A -6250.4% CRMD
FY2019 $30M $0M -71.5% -7416.3% NRIX
FY2020 $20M $0M -364.7% -11378.4% NRIX
FY2021 $30M $0M -396.3% -15417.5% NRIX
FY2022 $40M $0M -476.0% -46819.9% NRIX
FY2023 $80M N/A -201.4% N/A NRIX
FY2024 $50M $40M -390.5% -51.4% CRMD
FY2025 $80M $310M -340.2% 48.2% CRMD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NRIX (6) vs CRMD (4)
Institutional Metric NRIX CRMD Criterion Row Winner
Market Capitalization Scale $1.7B $384.7M Larger Scale NRIX
Trailing P/E Ratio Valuation 6.4x 2.4x Lower Multiple CRMD
Forward P/E Ratio Valuation N/M 49.0x Lower Multiple CRMD
Revenue Growth (YoY) Growth +8426.3% -47.7% Higher Growth NRIX
Operating Margin (TTM) Profitability 41.3% 41.0% Higher Margin NRIX
Net Profit Margin Profitability 42.0% 15.5% Higher Margin NRIX
Return on Equity (ROE) Capital Efficiency 44.0% 15.3% Higher ROE NRIX
52-Week Range Position Momentum 18% ($12โ€“$28) 3% ($5โ€“$13) Stronger Trend NRIX
Beta / 30D Volatility Risk Regime 0.94ฮฒ ยท 141% Vol 1.20ฮฒ ยท 107% Vol Lower Realized Risk CRMD
Unified Institutional Score Composite Signal 51.5 / 100 (HOLD) 53.2 / 100 (HOLD) Higher Composite CRMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NRIX vs CRMD Buy Guide
NRIX BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live NRIX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CRMD BREAKDOWN
109d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NRIX nor CRMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.